Behind Our Reporting on Puberty Blockers
We scoured the scientific evidence, interviewed doctors around the world and spoke to patients and families. Here’s a closer look at what we found.
We scoured the scientific evidence, interviewed doctors around the world and spoke to patients and families. Here’s a closer look at what we found.
Two sisters in one family died from a genetic disorder. Before a third child with the disease was born, doctors hatched a plan to spare her of its effects.
The analysis of 15 years of prescription data showed that the racial disparities are widening.
Federal officials are hoping that the encouraging results will spur more Americans to get an updated booster before a feared surge in coronavirus cases this winter.
The “nightmare variant” is not as bad as it sounds.
The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday.
Deaths from contaminated cough syrups in Gambia have brought attention to loose regulations in India and a lack of testing capacity in poor importing nations.
The report points to widespread misbehavior by the plans and the marketing firms they hire.
The agreement would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on for it to take effect.
New data suggests that abortion has declined about 2 percent in the U.S. since the end of Roe, accounting for people who traveled across state lines or ordered pills online.